The Latest Breaking News from FDA

The Department of Justice is asking the Supreme Court to review the Fifth Circuit's Rejection of the FDA's "Surprise Switcheroo."

Withings calls their Body Scan smart scale a "connected health station." With its premium build and price, it is exactly that and worth every penny, if you have it to spend.

The market offers many alternatives to bad desserts. We don’t need the FDA to step in.

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

In the name of safety, politicians did many things that diminished our lives—without making us safer.

Revamping cancer classification to focus on molecular characteristics over organ of origin can result in more effective and timely treatment, a group of doctors has said.

Lawsuit against Gilead Sciences raises concerns about innovation impact in drug development and potential implications on future product development.

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

That's the highest number in more than a decade, according to new research. Medication abortion made up a larger share of the total than in 2020.